328385-86-0Lisinopril EP Impurity C (Free Base)
● In Stock
| Catalogue No.: | VL600004 |
|---|---|
| CAS No.: | 328385-86-0 |
| Mol. Formula: | C21H29N3O4 |
| Mol. Weight: | 387.47 g/mol |
Additional information on CAS 328385-86-0
Parent drug
LisinoprilPharmacopeial Synonyms
Lisinopril Related Compound AIUPAC Name
(2S)-2-[(3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic acidSynonyms
Lisinopril S, S, S-DiketopiperazineSmiles
O=C(O)[C@@H](N([C@H]1CCCCN)C([C@@](CCC2)([H])N2C1=O)=O)CCC3=CC=CC=C3InChI
InChI=1S/C21H29N3O4/c22-13-5-4-9-17-19(25)23-14-6-10-16(23)20(26)24(17)18(21(27)28)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18H,4-6,9-14,22H2,(H,27,28)/t16-,17-,18-/m0/s1Description
Lisinopril EP Impurity C, also designated Lisinopril Related Compound A and Lisinopril (S,S,S)-diketopiperazine, is the cyclized degradation product of the ACE inhibitor lisinopril. The diketopiperazine ring arises through intramolecular condensation of the lysine and proline-derived amino acid functions, typically under thermal or acidic stress during synthesis or storage. CAS 328385-86-0, molecular formula C21H29N3O4, molecular weight 387.47 g/mol. Because this impurity reflects structural rearrangement rather than nitrosative chemistry, its toxicological concern is primarily impurity profiling rather than ICH M7 genotoxic classification. Quantification commonly relies on stability-indicating LC-MS/MS, LC-UV, and, where needed, high-resolution MS for confirmation.Request a Quote
"*" indicates required fields









